Clinical trial
A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Low-Dose Human Interferon-alpha During the 6-Month Follow-up Period of Standard Combination Therapy for Hepatitis C Virus Infection
NCT00695019 is registered in ClinicalTrials.gov with Ainos, Inc. (f/k/a Amarillo Biosciences Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Low-Dose Human Interferon-alpha During the 6-Month Follow-up Period of Standard Combination Therapy for Hepatitis C Virus Infection
- Lead sponsor
- Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- February 29, 2012
- Enrollment
- 169 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.